These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 17376862)
1. Establishing acceptance criteria for cell-mediated-immunity assays using frozen peripheral blood mononuclear cells stored under optimal and suboptimal conditions. Smith JG; Joseph HR; Green T; Field JA; Wooters M; Kaufhold RM; Antonello J; Caulfield MJ Clin Vaccine Immunol; 2007 May; 14(5):527-37. PubMed ID: 17376862 [TBL] [Abstract][Full Text] [Related]
2. Development and validation of a gamma interferon ELISPOT assay for quantitation of cellular immune responses to varicella-zoster virus. Smith JG; Liu X; Kaufhold RM; Clair J; Caulfield MJ Clin Diagn Lab Immunol; 2001 Sep; 8(5):871-9. PubMed ID: 11527795 [TBL] [Abstract][Full Text] [Related]
3. Temperature fluctuations during deep temperature cryopreservation reduce PBMC recovery, viability and T-cell function. Germann A; Oh YJ; Schmidt T; Schön U; Zimmermann H; von Briesen H Cryobiology; 2013 Oct; 67(2):193-200. PubMed ID: 23850825 [TBL] [Abstract][Full Text] [Related]
4. Measurement of cell-mediated immunity with a Varicella-Zoster Virus-specific interferon-gamma ELISPOT assay: responses in an elderly population receiving a booster immunization. Smith JG; Levin M; Vessey R; Chan IS; Hayward AR; Liu X; Kaufhold RM; Clair J; Chalikonda I; Chan C; Bernard M; Wang WW; Keller P; Caulfield MJ J Med Virol; 2003; 70 Suppl 1():S38-41. PubMed ID: 12627485 [TBL] [Abstract][Full Text] [Related]
5. The effect of apoptotic cells on virus-specific immune responses detected using IFN-gamma ELISPOT. Lenders K; Ogunjimi B; Beutels P; Hens N; Van Damme P; Berneman ZN; Van Tendeloo VF; Smits EL J Immunol Methods; 2010 May; 357(1-2):51-4. PubMed ID: 20214906 [TBL] [Abstract][Full Text] [Related]
6. Use of interferon-gamma ELISPOT in monitoring immune responses in humans. Matijevic M; Urban RG Methods Mol Biol; 2005; 302():237-52. PubMed ID: 15937356 [TBL] [Abstract][Full Text] [Related]
7. ELISPOT assays provide reproducible results among different laboratories for T-cell immune monitoring--even in hands of ELISPOT-inexperienced investigators. Zhang W; Caspell R; Karulin AY; Ahmad M; Haicheur N; Abdelsalam A; Johannesen K; Vignard V; Dudzik P; Georgakopoulou K; Mihaylova A; Silina K; Aptsiauri N; Adams V; Lehmann PV; McArdle S J Immunotoxicol; 2009 Dec; 6(4):227-34. PubMed ID: 19908941 [TBL] [Abstract][Full Text] [Related]
8. Immunization of patients with melanoma peptide vaccines: immunologic assessment using the ELISPOT assay. Pass HA; Schwarz SL; Wunderlich JR; Rosenberg SA Cancer J Sci Am; 1998; 4(5):316-23. PubMed ID: 9815296 [TBL] [Abstract][Full Text] [Related]
9. Detection of measles virus-specific interferon-gamma-secreting T-cells by ELISPOT. Ryan JE; Ovsyannikova IG; Poland GA Methods Mol Biol; 2005; 302():207-18. PubMed ID: 15937354 [TBL] [Abstract][Full Text] [Related]
10. Measuring T-cell function in animal models of tuberculosis by ELISPOT. Lazarevic V; Pawar S; Flynn J Methods Mol Biol; 2005; 302():179-90. PubMed ID: 15937352 [TBL] [Abstract][Full Text] [Related]
11. Design and validation of an enzyme-linked immunospot assay for use in clinical trials of candidate HIV vaccines. Mwau M; McMichael AJ; Hanke T AIDS Res Hum Retroviruses; 2002 Jun; 18(9):611-8. PubMed ID: 12079556 [TBL] [Abstract][Full Text] [Related]
12. CD4+ and CD8+ cells in cryopreserved human PBMC maintain full functionality in cytokine ELISPOT assays. Kreher CR; Dittrich MT; Guerkov R; Boehm BO; Tary-Lehmann M J Immunol Methods; 2003 Jul; 278(1-2):79-93. PubMed ID: 12957398 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of cytomegalovirus-specific T-cell reconstitution in patients after various allogeneic haematopoietic stem cell transplantation using interferon-gamma-enzyme-linked immunospot and human leucocyte antigen tetramer assays with an immunodominant T-cell epitope. Ohnishi M; Sakurai T; Heike Y; Yamazaki R; Kanda Y; Takaue Y; Mizoguchi H; Kawakami Y Br J Haematol; 2005 Nov; 131(4):472-9. PubMed ID: 16281937 [TBL] [Abstract][Full Text] [Related]
14. Critical parameters in blood processing for T-cell assays: validation on ELISpot and tetramer platforms. Afonso G; Scotto M; Renand A; Arvastsson J; Vassilieff D; Cilio CM; Mallone R J Immunol Methods; 2010 Jul; 359(1-2):28-36. PubMed ID: 20641145 [TBL] [Abstract][Full Text] [Related]
15. Assessment of critical parameters in blood processing for the bovine interferon-gamma ELISPOT assay to detect Mycobacterium bovis infected cattle in India. Veerasami M; Moorthy L; Das D; Parthasarathy S; Chandran D; Lingala R; Srinivasan VA Vet Ital; 2011; 47(1):25-34. PubMed ID: 21240848 [TBL] [Abstract][Full Text] [Related]
16. Detection of vaccinia virus-specific IFNγ and IL-10 secretion from human PBMCs and CD8⁺ T cells by ELISPOT. Umlauf BJ; Pinsky NA; Ovsyannikova IG; Poland GA Methods Mol Biol; 2012; 792():199-218. PubMed ID: 21956512 [TBL] [Abstract][Full Text] [Related]
17. Validation of a HLA-A2 tetramer flow cytometric method, IFNgamma real time RT-PCR, and IFNgamma ELISPOT for detection of immunologic response to gp100 and MelanA/MART-1 in melanoma patients. Xu Y; Theobald V; Sung C; DePalma K; Atwater L; Seiger K; Perricone MA; Richards SM J Transl Med; 2008 Oct; 6():61. PubMed ID: 18945350 [TBL] [Abstract][Full Text] [Related]
18. Development of an IFNγ ELISPOT for the analysis of the human T cell response against mumps virus. Han WG; Emmelot ME; Jaadar H; Ten Hulscher HI; van Els CA; Kaaijk P J Immunol Methods; 2016 Apr; 431():52-9. PubMed ID: 26872407 [TBL] [Abstract][Full Text] [Related]
19. Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT. Dean GA; LaVoy A; Burkhard MJ Vet Immunol Immunopathol; 2004 Jul; 100(1-2):49-59. PubMed ID: 15182995 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of pre-existent immunity in patients with primary breast cancer: molecular and cellular assays to quantify antigen-specific T lymphocytes in peripheral blood mononuclear cells. Rentzsch C; Kayser S; Stumm S; Watermann I; Walter S; Stevanoviç S; Wallwiener D; Gückel B Clin Cancer Res; 2003 Oct; 9(12):4376-86. PubMed ID: 14555509 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]